Welsh W - Search Results

1

Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1.

Passic SR, Ferguson ML, Catalone BJ, Kish-Catalone T, Kholodovych V, Zhu W, Welsh W, Rando R, Howett MK, Wigdahl B, Labib M, Krebs FC. Passic SR, et al. Among authors: welsh w. Biomed Pharmacother. 2010 Dec;64(10):723-32. doi: 10.1016/j.biopha.2010.10.001. Epub 2010 Nov 4. Biomed Pharmacother. 2010. PMID: 21106331 Free PMC article.

2

Specific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infection.

Thakkar N, Pirrone V, Passic S, Zhu W, Kholodovych V, Welsh W, Rando RF, Labib ME, Wigdahl B, Krebs FC. Thakkar N, et al. Among authors: welsh w. Antimicrob Agents Chemother. 2009 Feb;53(2):631-8. doi: 10.1128/AAC.00866-08. Epub 2008 Dec 1. Antimicrob Agents Chemother. 2009. PMID: 19047650 Free PMC article.

3

Persistent interactions between biguanide-based compound NB325 and CXCR4 result in prolonged inhibition of human immunodeficiency virus type 1 infection.

Thakkar N, Pirrone V, Passic S, Keogan S, Zhu W, Kholodovych V, Welsh W, Rando R, Labib M, Wigdahl B, Krebs FC. Thakkar N, et al. Among authors: welsh w. Antimicrob Agents Chemother. 2010 May;54(5):1965-72. doi: 10.1128/AAC.00934-09. Epub 2010 Mar 15. Antimicrob Agents Chemother. 2010. PMID: 20231400 Free PMC article.

4

Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation.

Paranjpe PV, Chen Y, Kholodovych V, Welsh W, Stein S, Sinko PJ. Paranjpe PV, et al. Among authors: welsh w. J Control Release. 2004 Nov 24;100(2):275-92. doi: 10.1016/j.jconrel.2004.08.030. J Control Release. 2004. PMID: 15544875

5

3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.

Peng Y, Keenan SM, Zhang Q, Kholodovych V, Welsh WJ. Peng Y, et al. J Med Chem. 2005 Mar 10;48(5):1620-9. doi: 10.1021/jm049117e. J Med Chem. 2005. PMID: 15743203

6

Volume learning algorithm significantly improved PLS model for predicting the estrogenic activity of xenoestrogens.

Kovalishyn VV, Kholodovych V, Tetko IV, Welsh WJ. Kovalishyn VV, et al. J Mol Graph Model. 2007 Sep;26(2):591-4. doi: 10.1016/j.jmgm.2007.03.005. Epub 2007 Mar 19. J Mol Graph Model. 2007. PMID: 17433745

7

Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.

Kimani SG, Kumar S, Bansal N, Singh K, Kholodovych V, Comollo T, Peng Y, Kotenko SV, Sarafianos SG, Bertino JR, Welsh WJ, Birge RB. Kimani SG, et al. Sci Rep. 2017 Mar 8;7:43908. doi: 10.1038/srep43908. Sci Rep. 2017. PMID: 28272423 Free PMC article.

8

In silico design of anti-atherogenic biomaterials.

Lewis DR, Kholodovych V, Tomasini MD, Abdelhamid D, Petersen LK, Welsh WJ, Uhrich KE, Moghe PV. Lewis DR, et al. Biomaterials. 2013 Oct;34(32):7950-9. doi: 10.1016/j.biomaterials.2013.07.011. Epub 2013 Jul 25. Biomaterials. 2013. PMID: 23891521 Free PMC article.

9

Shape signatures: new descriptors for predicting cardiotoxicity in silico.

Chekmarev DS, Kholodovych V, Balakin KV, Ivanenkov Y, Ekins S, Welsh WJ. Chekmarev DS, et al. Chem Res Toxicol. 2008 Jun;21(6):1304-14. doi: 10.1021/tx800063r. Epub 2008 May 8. Chem Res Toxicol. 2008. PMID: 18461975 Free PMC article.

10

Computational discovery of novel low micromolar human pregnane X receptor antagonists.

Ekins S, Kholodovych V, Ai N, Sinz M, Gal J, Gera L, Welsh WJ, Bachmann K, Mani S. Ekins S, et al. Mol Pharmacol. 2008 Sep;74(3):662-72. doi: 10.1124/mol.108.049437. Epub 2008 Jun 25. Mol Pharmacol. 2008. PMID: 18579710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters